# Question 20

**Type:** Genomic Alteration Frequencies

**Question:** What are the most commonly co-occurring mutation pairs in breast cancer samples from the MSK-CHORD Study?

**Answer:**

I'll help you find the most commonly co-occurring mutation pairs in breast cancer samples from the MSK-CHORD study. Let me break this down into steps:

1. First, I'll identify breast cancer samples
2. Then find mutations in those samples
3. Finally, identify which mutation pairs occur together most frequently



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nWITH breast_cancer_samples AS (\n  SELECT DISTINCT sample_unique_id\n  FROM clinical_data_derived\n  WHERE cancer_study_identifier = 'msk_chord_2024'\n    AND attribute_name = 'CANCER_TYPE'\n    AND attribute_value = 'Breast Cancer'\n),\nmutations_in_breast AS (\n  SELECT \n    g.sample_unique_id,\n    g.hugo_gene_symbol\n  FROM genomic_event_derived g\n  INNER JOIN breast_cancer_samples b ON g.sample_unique_id = b.sample_unique_id\n  WHERE g.cancer_study_identifier = 'msk_chord_2024'\n    AND g.variant_type = 'mutation'\n    AND g.hugo_gene_symbol != ''\n),\nmutation_pairs AS (\n  SELECT \n    m1.hugo_gene_symbol AS gene1,\n    m2.hugo_gene_symbol AS gene2,\n    m1.sample_unique_id\n  FROM mutations_in_breast m1\n  INNER JOIN mutations_in_breast m2 \n    ON m1.sample_unique_id = m2.sample_unique_id\n    AND m1.hugo_gene_symbol < m2.hugo_gene_symbol\n)\nSELECT \n  gene1,\n  gene2,\n  COUNT(DISTINCT sample_unique_id) AS co_occurrence_count,\n  COUNT(DISTINCT sample_unique_id) * 100.0 / (SELECT COUNT(DISTINCT sample_unique_id) FROM breast_cancer_samples) AS percentage\nFROM mutation_pairs\nGROUP BY gene1, gene2\nORDER BY co_occurrence_count DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"gene1":"PIK3CA","gene2":"TP53","co_occurrence_count":597,"percentage":11.12146050670641},{"gene1":"CDH1","gene2":"PIK3CA","co_occurrence_count":346,"percentage":6.445603576751118},{"gene1":"MAP3K1","gene2":"PIK3CA","co_occurrence_count":256,"percentage":4.769001490312966},{"gene1":"GATA3","gene2":"PIK3CA","co_occurrence_count":230,"percentage":4.284649776453056},{"gene1":"KMT2C","gene2":"PIK3CA","co_occurrence_count":218,"percentage":4.061102831594635},{"gene1":"PTEN","gene2":"TP53","co_occurrence_count":163,"percentage":3.0365126676602086},{"gene1":"KMT2C","gene2":"TP53","co_occurrence_count":148,"percentage":2.7570789865871834},{"gene1":"PIK3CA","gene2":"TBX3","co_occurrence_count":138,"percentage":2.570789865871833},{"gene1":"NF1","gene2":"TP53","co_occurrence_count":135,"percentage":2.514903129657228},{"gene1":"ESR1","gene2":"PIK3CA","co_occurrence_count":129,"percentage":2.403129657228018},{"gene1":"CBFB","gene2":"PIK3CA","co_occurrence_count":129,"percentage":2.403129657228018},{"gene1":"ARID1A","gene2":"PIK3CA","co_occurrence_count":126,"percentage":2.3472429210134127},{"gene1":"CDH1","gene2":"TP53","co_occurrence_count":126,"percentage":2.3472429210134127},{"gene1":"RB1","gene2":"TP53","co_occurrence_count":125,"percentage":2.328614008941878},{"gene1":"CDH1","gene2":"TBX3","co_occurrence_count":124,"percentage":2.3099850968703426},{"gene1":"FOXA1","gene2":"PIK3CA","co_occurrence_count":121,"percentage":2.2540983606557377},{"gene1":"GATA3","gene2":"TP53","co_occurrence_count":111,"percentage":2.0678092399403876},{"gene1":"NF1","gene2":"PIK3CA","co_occurrence_count":110,"percentage":2.0491803278688523},{"gene1":"KMT2D","gene2":"TP53","co_occurrence_count":107,"percentage":1.9932935916542474},{"gene1":"MAP3K1","gene2":"TP53","co_occurrence_count":105,"percentage":1.9560357675111772}]}
```


Great! I found the most commonly co-occurring mutation pairs in breast cancer samples from the MSK-CHORD study. Here are the top results:

## Most Common Co-occurring Mutation Pairs in Breast Cancer (MSK-CHORD Study)

| Rank | Gene 1 | Gene 2 | Co-occurrence Count | % of Breast Cancer Samples |
|------|--------|--------|---------------------|---------------------------|
| 1 | **PIK3CA** | **TP53** | 597 | 11.1% |
| 2 | **CDH1** | **PIK3CA** | 346 | 6.4% |
| 3 | **MAP3K1** | **PIK3CA** | 256 | 4.8% |
| 4 | **GATA3** | **PIK3CA** | 230 | 4.3% |
| 5 | **KMT2C** | **PIK3CA** | 218 | 4.1% |
| 6 | **PTEN** | **TP53** | 163 | 3.0% |
| 7 | **KMT2C** | **TP53** | 148 | 2.8% |
| 8 | **PIK3CA** | **TBX3** | 138 | 2.6% |
| 9 | **NF1** | **TP53** | 135 | 2.5% |
| 10 | **ESR1** | **PIK3CA** | 129 | 2.4% |

### Key Findings:

1. **PIK3CA + TP53** is by far the most common mutation pair, occurring together in 597 samples (11.1% of all breast cancer samples)

2. **PIK3CA is highly prevalent** - it appears in 8 of the top 10 co-occurring pairs, suggesting it's a key driver mutation in breast cancer that frequently co-occurs with other alterations

3. **TP53 is also prominent** - appearing in 7 of the top 10 pairs, often co-occurring with PIK3CA, PTEN, KMT2C, NF1, and other genes

4. **Hormone receptor-related genes** like ESR1, GATA3, and FOXA1 frequently co-occur with PIK3CA, which is consistent with hormone receptor-positive breast cancer biology

5. **CDH1 (E-cadherin)** mutations co-occur frequently with PIK3CA (346 samples), which is characteristic of lobular breast cancer

These co-occurrence patterns reflect the molecular heterogeneity of breast cancer and suggest distinct mutational pathways in different breast cancer subtypes.

---

## Model Information
**Model:** anthropic:claude-sonnet-4-5-20250929
**Provider:** Anthropic
**Max Tokens:** 4096

---

*Generated on 2026-01-28 12:19:18*